Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF4707 - Provider product page
- Provider
- R&D Systems
- Product name
- Human DC-SCRIPT/ZNF366 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Detects human DC-SCRIPT/ZNF366 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human (rh) ZNF24 and rhZNF206 is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Unconjugated
- Antigen sequence
Q8N895
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references DC-SCRIPT regulates glucocorticoid receptor function and expression of its target GILZ in dendritic cells.
Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production.
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Hontelez S, Karthaus N, Looman MW, Ansems M, Adema GJ
Journal of immunology (Baltimore, Md. : 1950) 2013 Apr 1;190(7):3172-9
Journal of immunology (Baltimore, Md. : 1950) 2013 Apr 1;190(7):3172-9
Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production.
Hontelez S, Ansems M, Karthaus N, Zuidscherwoude M, Looman MW, Triantis V, Adema GJ
Journal of immunology (Baltimore, Md. : 1950) 2012 Jul 1;189(1):138-45
Journal of immunology (Baltimore, Md. : 1950) 2012 Jul 1;189(1):138-45
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M, Hontelez S, Looman MW, Karthaus N, Bult P, Bonenkamp JJ, Jansen JH, Sweep FC, Span PN, Adema GJ
Journal of the National Cancer Institute 2010 Jan 6;102(1):54-68
Journal of the National Cancer Institute 2010 Jan 6;102(1):54-68
No comments: Submit comment
Supportive validation
- Submitted by
- R&D Systems (provider)
- Main image
- Experimental details
- Detection of DC-SCRIPT/ZNF366 in Human Mature Dendritic Cells by Flow Cytometry. Human mature dentritic cells differentated from human peripheral blood mononuclear cell derived CD14+ cells treated with 20 ng/mL Recombinant Human IL-4 (Catalog # 204-IL) and 50 ng/mL Recombinant Human GM-CSF (Catalog # 215-GM) for 7 days and 1 μg/mL LPS, 20 ng/mL Recombinant Human TNF-alpha (Catalog # 210-TA), and 20 ng/mL Recombinant Human IL-1 beta/IL-1F2 (Catalog # 201-LB) for last 24 hours were stained with Human DC-SCRIPT/ZNF366 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4707, filled histogram), or control antibody (Catalog # AB-108-C, open histogram), followed by Donkey Anti-Goat IgG (H+L) Phycoerythrin (Catalog # F0107). To facilitate intracellular staining, cells were fixed with paraformaldehyde and permeabilized with saponin.